A New Family of Giardial Cysteine-Rich Non-VSP Protein Genes and a Novel Cyst Protein by Davids, Barbara J. et al.
A New Family of Giardial Cysteine-Rich Non-VSP Protein
Genes and a Novel Cyst Protein
Barbara J. Davids
1.*, David S. Reiner
1., Shanda R. Birkeland
2, Sarah P. Preheim
3, Michael J. Cipriano
2, Andrew G. McArthur
2, Frances D. Gillin
1
1Department of Pathology, Division of Infectious Diseases, University of California, San Diego, California, United States of America, 2Josephine Bay
Paul Center for Comparative Molecular Biology and Evolution, Marine Biological Laboratory, Woods Hole, Massachusetts, United States of America,
3Department of Biology, Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, United States of America
Since the Giardia lamblia cyst wall is necessary for survival in the environment and host infection, we tested the hypothesis
that it contains proteins other than the three known cyst wall proteins. Serial analysis of gene expression during growth and
encystation revealed a gene, ‘‘HCNCp’’ (High Cysteine Non-variant Cyst protein), that was upregulated late in encystation, and
that resembled the classic Giardia variable surface proteins (VSPs) that cover the trophozoite plasmalemma. HCNCp is 13.9%
cysteine, with many ‘‘CxxC’’ tetrapeptide motifs and a transmembrane sequence near the C-terminus. However, HCNCp has
multiple ‘‘CxC’’ motifs rarely found in VSPs, and does not localize to the trophozoite plasmalemma. Moreover, the HCNCp C-
terminus differed from the canonical VSP signature. Full-length epitope-tagged HCNCp expressed under its own promoter was
upregulated during encystation with highest expression in cysts, including 42 and 21 kDa C-terminal fragments. Tagged
HCNCp targeted to the nuclear envelope in trophozoites, and co-localized with cyst proteins to encystation-specific secretory
vesicles during encystation. HCNCp defined a novel trafficking pathway as it localized to the wall and body of cysts, while the
cyst proteins were exclusively in the wall. Unlike VSPs, HCNCp is expressed in at least five giardial strains and four WB
subclones expressing different VSPs. Bioinformatics identified 60 additional large high cysteine membrane proteins (HCMp)
containing $20 CxxC/CxC’s lacking the VSP-specific C-terminal CRGKA. HCMp were absent or rare in other model or parasite
genomes, except for Tetrahymena thermophila with 30. MEME analysis classified the 61 gHCMp genes into nine groups with
similar internal motifs. Our data suggest that HCNCp is a novel invariant cyst protein belonging to a new HCMp family that is
abundant in the Giardia genome. HCNCp and the other HCMp provide a rich source for developing parasite-specific diagnostic
reagents, vaccine candidates, and subjects for further research into Giardia biology.
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a Novel Cyst Protein. PLoS ONE 1(1): e44. doi:10.1371/journal.pone.0000044
INTRODUCTION
Giardiasis is a major contributor to the enormous burden of
human diarrheal diseases, which are second only to respiratory
infections as causes of mortality and morbidity worldwide [1–3].
Although diarrheal diseases rarely kill children in the USA, they
remain important causes of infant death in less-developed
countries [2,4,5]. Unlike the rotaviruses, which affect infants,
giardiasis can also hamper adults in their productive years. In the
USA, G. lamblia has been one of the most frequently identified
causes of water-borne intestinal disease, and causes diarrhea in
daycare centers and among hikers and campers. Nonetheless, the
basic biology and pathogenesis of this parasite remain incom-
pletely understood. Although trophozoites do not invade or secrete
any known toxin [2,6], they can cause severe diarrhea that can
cause failure of children to thrive. However, about half of infected
people lack symptoms and the infection often resolves without
treatment. Thus, both the duration and symptoms of giardiasis are
highly variable in immunocompetent people for reasons that are
not understood.
No giardial virulence factor is known and this protist’s ability to
survive in diverse, hostile environments may be a key to its
pathophysiology. To survive within the small intestine, Giardia
trophozoites are covered with a single layer of an unusual Type 1
integral membrane protein that protects them from proteolysis [7].
Normally, each trophozoite expresses only one such surface
protein from approximately 150 in the genome and switching of
these variant-specific surface proteins (VSPs) [8–10] likely protects
the trophozoite surface from both immunologic and environmen-
tal attack. VSP gene expression can spontaneously switch both in
vitro and in vivo [11,12] every six to thirteen generations [13]. Most
isolates are mixed populations of trophozoites expressing different
VSPs. Immune [11] or environmental [14] stress in vitro can select
for or against expression of different VSPs, which are usually not
immunologically cross-reactive [15], suggesting that a major
function of antigenic variation is immune evasion. VSPs are
extremely (,12%) cysteine-rich, with most Cys residues in a CxxC
motif, where x can be any amino acid [16,17]. Although VSPs
differ in size and sequence, they are characterized by a highly
conserved C-terminal membrane spanning region, a hydrophilic
cytoplasmic tail with a conserved five amino acid CRGKA
signature sequence, and an extended polyadenylation signal
[7,8,18].
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must encyst in order to survive outside the host [8]. Encystation is
characterized by construction of an extracellular cyst wall which
protects the parasite from hypotonic lysis in the external
environment and from gastric acid when infecting a new host
[8,19,20]. The Giardia’ cyst wall is biologically important as
a simple model extracellular matrix, with both structural and
signal transduction functions [21,22]. Encystation contributes to
immune evasion [23] by two distinct pathways: first, the cyst wall
covers the trophozoite surface during encystation and sequesters it
from host defenses and second, encystation leads to switching of
VSPs [18,24,25]. Despite its importance, the composition,
architecture, and formation of the cyst wall are poorly understood.
Only three structural cyst wall proteins (CWPs) have been
identified [26–28]. CWPs 1–3, which do not undergo antigenic
variation, have 14–16 Cys residues and similar leucine rich repeats
(LRRs). In addition to CWPs, the cyst wall is also composed of
fibrils of poly N-acetylgalactosamine [29–31].
The VSPs and CWPs define distinct expression and trafficking
patterns [26–28,32]. A well-studied VSP called TSA 417 was
highly expressed during vegetative growth and transported by
a conventional ER pathway to the plasmalemma [32]. TSA 417
was downregulated and the protein internalized during encysta-
tion. In contrast, CWPs are only expressed during encystation and
are exclusively transported to the cyst wall within the matrix of
novel regulated encystation secretory vesicles (ESVs) [33–36].
They do not localize to the plasma membrane. Neither the ESVs
nor the cyst wall contains VSPs.
In theses studies, we tested the hypothesis that the cyst wall may
contain additional proteins. Recently, our ongoing transcriptome
analyses of the giardial life cycle revealed a gene encoding an
unusual VSP-like protein that was upregulated during encystation.
Functional and bioinformatic analyses showed that this gene
encodes a divergent cysteine-rich protein (HCNCp) that is
increasingly expressed in the cyst cell body and cyst wall during
encystation and does not vary among giardial isolates. HCNCp
may provide a functional link between immune avoidance and
differentiation.
RESULTS
Identification of HCNCp
A major goal of the giardial transcriptome analysis was to identify
new genes whose expression patterns suggest an important role in
differentiation. Correcting for sequencing error, we sampled
36,000–39,000 SAGE tags throughout the Giardia lamblia life
cycle, except for 21 hours encystation, in which we were only able
to sample 18,370 tags. 83.6% of all 15 bp SAGE tag sequences
could be mapped to a single location in the 12 Mbp ‘‘giardia14’’
genome assembly, with an additional 9.0% mapping to multiple
locations primarily due to duplicated genes. In addition to
numerous upregulated transcripts, we identified ORF 40376
(originally annotated as a large VSP) as a gene significantly
upregulated from 12 to 42 hr of encystation (Figure 1). Northern
analyses confirmed an increase in the transcript for this gene
during encystation (data not shown). ORF 40376 encodes a large
gene of 3790 bp (1609 amino acids) and the encoded protein has
a predicted molecular weight of 169,301.7 kDa. We named the
gene product High Cysteine Non-variant Cyst protein (HCNCp)
(GenBank accession DQ144994). Like the VSPs, HCNCp is
a strikingly cysteine-rich (13.9%), acidic (theoretical pI 4.72), Type
1 integral membrane protein with multiple CxxC and GGCY
motifs (Tables 1 and 3), although it did not have a Zn finger motif.
It has a typical N-terminal signal peptide sequence whose
predicted cleavage site is between amino acids 14 and 15. Also
like the VSPs, HCNCp has a single C-terminal membrane
spanning region and short cytoplasmic tail. However, the
predicted C-terminal transmembrane (TM) region of HCNCp is
divergent from those of the VSPs (1577-GAITGIAIAVIAVIG-
CAVGVLVW-1599) with a similar, but distinct amino acid tail,
CRRSKAV for HCNCp versus CRGKA for the VSPs (Table 1).
While VSPs utilize a unique extended polyadenylation signal
[8,18], the polyadenylation signal for HCNCp matches that of the
majority of non-VSP genes within the G. lamblia genome
(AGTAAAT). MEME analysis did not find a unique putative
promoter sequence shared between HCNCp and the VSPs or
CWPs, although HCNCp did share a typical AT-rich putative
transcription initiation signal with the CWPs. There was no
evidence of the C(T/A)ACAG promoter sequence associated with
gMyb2 [37], a Myb-related protein involved in upregulation of
CWPs and G6PI-B [38] during encystation.
HCNCp Protein Is Upregulated During Encystation
and Does Not Traffic to the Plasma Membrane
Based on its degree of similarity to the VSPs, we tested the
hypothesis that HCNCp is a large variable cysteine-rich protein
increasingly expressed on the trophozoite surface during encysta-
tion. We expressed full-length (,170 kDa) HCNCp under its own
promoter with a small C-terminal epitope-tag to evaluate protein
expression profiles. Full-length HCNCp was faintly detected in
trophozoites, but increasingly expressed at 21 and 42 hr of
encystation and highest in water-resistant cysts (Figure 2). The
protein expression profile of HCNCp is similar to its stable mRNA
levels (Figure 1). Epitope-tagged (C-terminal) fragments of 42 and
21 kDa also increased during encystation. These are likely
physiologically processed C-terminal fragments, as the antigens
are prepared by trichloroacetic acid precipitation of live parasites
in the presence of proteinase inhibitors to prevent degradation.
Figure 1. HCNCp mRNA Transcripts Are Upregulated During Encysta-
tion
SAGE revealed increased steady state abundance of HCNCp transcripts
beginning at 12 hr encystation through 42 hr compared to trophozoite
(‘‘troph’’) and 4 hr encystation. SAGE data is presented as percentage of
all tags sampled at a given time point.
doi:10.1371/journal.pone.0000044.g001
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ORF MW % C CxxC CxC Transmembrane C-terminus
112633 179.9 11 6 28 AIVVVVLLVLAAVAGFLVWWFVI RPRKSGVLRERAPRKPGRGLPKPQLTRNSSLTASMYSTAPLLNGSRQPSMVQL
137727 178.5 11 6 28 AIVVVVLLVLVAVAGFLIWWFVI RPRRGGPLRERAPQKGSKSSRSKLKRQATSNASLHADVPLLSQLSGANSSIQL
113213 177.3 11 6 28 AIVVVVLLVLVAVAGFLVWWFVI RPRRGGPLRERAPRKPPGLPKPQLTHNSSLTASMYSTAPLLSGSRQSSMVQL
113836 176.1 11 6 28 AIVVVVLLVLVAVAGFLVWWFVI RPRRGGPLRERVPQKGSKSSSSSRSKLRRQADSSVSLHADVPLLSQASNVNSSIQL
113531 178.1 11 6 28 IAVVVVVLLVLVAVAGFLVWWFV IRPRKSGELRERAPRKGPSFSGSQKLKKQASSKASLHATAPLLSRSSHAGSSVQL
114626 177.9 11 6 28 IAVVVVVLLVLVAVAGFLVWWFV IRPRKSGELRERAPRKGPSFSGSQKLKKQASSKASLHATAPLLSRSSHAGSSVQL
16936 162.6 11 4 26 IIVVVVVALVILAVAIFLIWKFV IKPRSKSRKRSNNDLNQRLITVDGEDAPVLSPRARGQTLM
27717 86.5 11 34 0 AIAAIVIVVLLVLAVAGFLVWWF VFRRGGRPKRGAKYTSLMRGESYDYRQSLI
112126 85.8 12 34 0 AIAAIVIVVLLVLAVAGFLVWWF VFRRGGRPKRGAKYTSLMRGESYDYRQSLI
113987 86.2 12 34 0 AIAAIVIVVLLVLAVAGFLVWWF VFRRGGRPKRGAKYTSLMRGESYDYRQSLI
114891 85.7 12 34 0 AIAAIVIVVLLVLAVAGFLVWWF VFRRGGRPKRGAKYTSLMRGESYDYRQSLI
91707 71.9 11 21 3 VTVAVVVSLLIIAAVALACWLVL RRRRGSKIVSRKRTAAENIKLMGSVDEF
112673 121.5 13 56 1 AGVSVTAILLVTGLVSFLLWWFL CKRT
112135 120.8 13 56 1 AGVSVTAVLLVTGLVSFLLWWFL CRRSR
115066 122.5 13 56 0 GVSVAAVLLVGSVVGFLLWWFLY RRTQPYGAKHVALSRKRIPTTASITTPLN
24880 98.9 13 4 17 GVLIGTSVGGVVLLIAIIVGVFF CVKKARKGKAPEGRAGKKTRALLSDGDDEDEDLLVPSESESGSASAATGTDEIP
16374 79.6 13 19 6 IAGLSVGSIILLTAVALSIYFGV RACQKKNRSQVSFSRTVPIGDEDCNP
11309 140.4 14 69 3 IGLSVTAVALLLIALGILLWKLL SARKLSRTRCMHLPGSTTELLAGASGTGQSMIFDSINLSIT
10659 74.4 12 31 0 GIAVAVIIVVGGLVGFLCWWFIY RGRK
TSA 417 72.5 12 29 0 GISVAVIVVVGGLIGFLCWWFL CRGKA
113512 60.4 11 21 0 GVSVVVIIVVGGLAGFLCWWFI GRRKA
114470 58.9 11 21 0 SPSAIAGVSVVVIIVVGGLAGFL C
16842 75.9 11 28 1 AVGVTIAILAIAGVIGFLVWWFV CKKKTNKVNMPPKLSSNSSIVSSRIGLM
16318 220.5 12 30 25 GSVIAVLLVLGGVIGFCVWWFLV RGKKGQAAQKGRRGKSYSGRKYVRTVSDPDSTSLLSTDMTNSLL
114991 153.5 11 5 24 YVPIVVGVLVLSVLAGLIGFLSW RFCCKNKKPKHPLDIPTKRRGRRERSAIALISYANFRGRNANEAMGLAELEEGSDGSAAV
112584 86.0 12 34 1 GIAIGVVLVVGGVAAVLVWFFVF RKKN
113297 87.3 12 34 1 GIAIGVVLVVGGVAAVLVWFFVF RKKAGVPLLYKQSIVASTH
113801 85.4 13 34 1 GIAIGVVLVVGGVAAVLVWFFVF RKKN
137672 85.6 13 34 1 GIAIGVVLVVGGVAAVLVWFFVF RKKN
112305 86.1 12 34 1 GIAIGVVLVVGGVAGVLVWVFVF RKKAGVPPLYKQSIVASTH
114852 85.2 13 34 1 GIAISVVLVVGGVAGVLVWFFVF RKKN
15317 169.6 12 24 22 ITIAVLVVVGGSVAGVLVWFFLF RNRKGPMKKSPRRRFHPDETSTSLLSQDYGSSML
HCNCp 169.4 14 77 8 ITGIAIAVIAVIGCAVGVLVWFL CCRRSKAV
39904 85.6 12 30 2 AGISVASVAIVAVIIGCLVWFLL RRKNSGSLNREPSLFRPLSS
25816 99.6 12 38 1 GVVAGISITIVVVVAAIVGVLVW KYVCKKKSSKRIKMVDMDVSINTSQYMSTSTV
113416 262.0 13 108 1 AITGITLGVAVLVGGAIGLALGL TVCKRGCAGNGSLQPLTI
114180 263.8 13 110 1 AITGITLGVAVLVGGAIGLALGL TVCKRGCAGSTGEGLRPLYA
113319 265.7 13 110 2 AITGITLGVTVLVGGTIGLTFSL MASKHKSQASGLRPLTA
17328 139.8 16 70 18 ATAISCSVIGAAIAIATTIALIV KCQHHRHARMVRQVDALVTEADELAH
91099 145.5 12 5 25 IGAVAGVTASTAVFFGLLFLSAA RCHRTPAR
103454 79.4 11 22 1 GIGVGVSVVVLVLIGVLIWWLVF QRRRGSGFGGSRDMLTSRD
101805 82.6 11 22 1 VIIGICVGAVLIMGALIGVLAWW VVSRKKKSASFERSRSLVISKS
114042 87.1 12 24 3 IAGGTVAGVAVIGVLVGFLCWWF LCRGKRIGASPSTTALVRPKSV
114089 85.8 12 24 3 IAGGTVAGVVVIGVLVGFLCWWF LCRSKHIGASSSTTALVRSKSV
114617 84.8 12 23 3 TAAIAGGTVAGVIVIGSLVGFL CW
112828 86.0 11 24 3 AGTTMAVLVVGVLVGFLCWWFIF RGRRIDASPSTMTLISSKSM
114930 84.8 12 24 3 ASAASAVLVISALIGFLCWWFI CRGKRRYYR
32607 88.3 12 38 0 MEISVAMVAIGALVGFLCWWFIF RGRRIDASPSTMTLIPSKSI
7715 72.8 11 20 3 IAIAVIVIVVIVGVLVGVLCWYF LRNKRKRSIRPRTVSKMSESMGLVGSVDDF
9620 87.8 15 50 0 SSLALFIIMLSLIILWIVVILIV RYKEGARQHITTSLSNTETI
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PLoS ONE | www.plosone.org 3 December 2006 | Issue 1 | e44Nonetheless, we cannot be certain that the native HCNCp
processes the same way as epitope-tagged HCNCp.
In vegetative trophozoites, HCNCp was primarily localized to
the nuclei (Figure 3), as shown by DAPI staining. Double staining
with antibody to protein disulfide isomerase 2 (PDI2; [39]; data
not shown) confirmed that some HCNCp was located to the
nuclear envelope, which is the first cisterna of the ER. Encystation
is not synchronous and we observed this nuclei/ER staining in
some encysting cells (not shown). We found that during
encystation, HCNCp traffics through the encystation secretory
vesicles (ESV), which export CWPs. Double staining with rabbit
anti-cyst antibody, which co-localized with cwp-1 and –2 to the
ESV and cyst wall (not shown), showed co-localization of cyst
proteins with HCNCp in ESV (Figure 3). Double staining also
showed HCNCp in the wall of mature, water-resistant cysts.
However, in contrast to the cyst proteins that were exclusively in
the cyst wall, most of the HCNCp localized to the cell body of the
cyst that becomes the excyzoite (Figure 3). We have not observed
HCNCp in the plasmalemma of vegetative or encysting tropho-
zoites, even though our epitope-tag contains the C-terminal
predicted TM sequence.
HCNCp is a Unique Non-Variant Cyst Protein
We searched the G. lamblia genome for sequences unique to
HCNCp in order to develop HCNCp-specific internal PCR
primers. We used these primers to detect the HCNCp gene and
mRNA transcripts in different Giardia isolates. Isolate WB (clone
C6) expresses the VSP called TSA 417 and 1F, A6, and E6 are
subclones derived from WB C6 that do not express TSA 417 [24].
Bris, RB, and LT are unrelated human isolates, while D3 was
isolated from a dog (American Type Culture Collection; ATCC).
All are in Assemblage A [8]. We detected the HCNCp gene
(Figure 4A) and transcript (Figure 4B) in trophozoites of all
strains/subclones except GS/M, which belongs to Assemblage B
and is considered the most distant Giardia strain infecting humans
[40]. Other primer sets we tested also did not detect HCNCp in
GS/M. The GS/M strain either does not have the gene or it is too
dissimilar to be detected with the primer sets used. These data
suggest that HCNCp is not a classical giardial VSP, but a new
invariant cyst protein.
Identification of other non-VSP cysteine-rich
membrane proteins
We searched the G. lamblia genome for additional genes encoding
a Type 1 integral membrane, high Cys containing proteins
(HCMp) lacking the canonical VSP cytoplasmic tail sequence
CRGKA (Table 1). Other search parameters were that the protein
contain $400 amino acids, $10% Cys and $20 CxC and or
CxxC. Of the 60 proteins we identified, none had specific
sequence homology to HCNCp, but many contained the CxC
motif that appears eight times in HCNCp, yet is rarely found in
VSPs [16,40]. Only one HCMp (ORF 17328) used the extended
ORF MW % C CxxC CxC Transmembrane C-terminus
14017 89.7 14 47 0 LIVGVIVFIIVLILIVVTVVLLI RLRKRMDREDAIFCEQNTTLIPDGQGLEYQDSEEP
15008 62.5 11 19 2 IAVGVAASVVGIMVVALVCWLVL GVSSCLTCIENCAECKQTGTASFEC
15250 66.9 14 32 0 ASSVGIVVLVLLVCIGVGLFFVF RRKPAQQLDVTSETRLMNSQKNMEPTSVDTNPECVEYETD
15475 62.6 13 31 1 WLYMWMMFVLFSGLMLLAFLS TCFKKVLVAKEQSRPSSTCDSVSKDKRC
15521 56.7 12 24 3 SITLPLAVLLLAATVITLAIILV KKRKTTKHGLSTNPVTLTTMVST
16716 72.6 14 36 0 VTAAIVILVLLLIGVCAAIPFIV KVLVRKGVRRRTRAMKYDRGSADSLLPEGSADSAL
16721 66.9 12 30 0 IVGISAGVILAVGIIAGAIVMTV TSKKHK
21321 72.8 14 36 0 VTAAIVILVLLLIGVCAAIPFIV KVLVRKGVRRRTRAMKYDRGSADSLLPEGSADSAL
22547 109.1 15 61 2 VVLGAALAISFAGGSSIALYFII RRLLQ
41942 61.7 14 30 0 ISSVSATVLVLLACIGIGLFFIF RRRSPRLDAASEALSVETLQEHELSRQC
112432 70.1 14 35 0 LISTIVILGLIIVGFIVATPFLV KLAKKRGVRVSKLRSINSGSESHNEFLLEEPDLL
137715 71.9 14 36 0 LISTIVILGLIIVGFIVATPFLV KLAKKRGVRVSKLRSINSGSESHNEFLLEEPDLL
The prototypical VSP (TSA 417) is included for comparison. ORF ID numbers can be used to view the data on GiardiaDB (www.mbl.edu/Giardia).
doi:10.1371/journal.pone.0000044.t001
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Figure 2. Expression of HCNCp During Differentiation
Full length epitope-tagged HCNCp protein (arrow at 170 kDa) was
detected beginning at 21 hr encystation (‘‘21’’) and was at peak levels
at the cyst (‘‘C’’) stage. Proteins having an AU1 tag and relative
molecular masses of 42 and 21 kDa also increased during encystation
(arrows). Anti-AU1 antibodies did not react to non-transfected ‘‘control’’
trophozoites (‘‘T’’) or encysting cells (‘‘21’’, ‘‘42’’, or ‘‘C’’). Size markers are
indicated by dashes on the left side of figure in kDa and the taglin
loading control is shown at the bottom of the figure (‘‘LC’’).
doi:10.1371/journal.pone.0000044.g002
Table 1. cont.
..................................................................................................................................................
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PLoS ONE | www.plosone.org 4 December 2006 | Issue 1 | e44VSP polyadenylation signal [8,18], while all others utilized the
conventional Giardia polyadenylation signal. SAGE data was
available for a number of these HCMp (Table 2), but only five
had evidence of changes in expression during encystation. ORFs
16318 and 25816 were upregulated in 4–12 hr encystation, while
ORFs 11309, 14017, and 15317 were approximately equal in
abundance in trophozoites and during encystation, but nearly
absent at 42 hr encystation. Each of these five proteins is a large,
VSP-like protein with epidermal growth factor (EGF)-like motifs
(Table 3). We also found 26 ORFs (18 were ,400 aa) that were
$10% Cys that had a single TM domain and no CRGKA tails,
but they did not have $20 CxC/CxxC motifs (Table S1).
We found that cysteine-rich ($10%), Type 1 integral mem-
brane proteins with $20 CxC and/or CxxC are absent or rare in
most completed genomes (Table 4). For example, we found no
representatives in the parasites Toxoplasma gondii, Trypanosoma brucei,
Plasmodium falciparum, or Cryptosporidium parvum or in the yeast and
plant model organisms Saccharomyces cerevisiae, Arabidopsis thaliana
and Chlamydomonas rheinhardtii. In contrast, we found 6 HCMp’s in
the intestinal dwelling, cyst-forming human parasite Entamoeba
histolytica, 4 each in Caenorhabditis elegans and Drosophila melanogaster,
and 7 in humans. Surprisingly, the genome of the ciliated
protozoan Tetrahymena thermophila has 30 HCMp. This number is
still far fewer than Giardia if the genome size is considered. Based
on predicted ORFs, T. thermophila has 5 times fewer HCMp than
Giardia (Table 4). These 30 ORFs had high expectation values
(from 0.0035 to 4.6e
208) to the TMK-like HMM from E. histolytica
and half of them had between 1 and 25 PC6B motifs.
Bioinformatic analyses of HCMp
36 of the giardial HCMp are annotated as VSPs in the Giardia
Genome Database (www.mbl.edu/Giardia[41]), nine as notch/
EGF receptor-like [42], and 16 as E. histolytica receptor kinase-like
proteins [43]. We used comparative motif analyses with the
Figure 3. Traffic of HCNCp And Cyst Proteins During Growth And Differentiation
Differential interference contrast (DIC) merged with DAPI images are shown to the left of each panel, HCNCp in green, anti-cyst proteins in red, and
nucleic acid in blue (DAPI). In trophozoites, HCNCp localized to nuclei and nuclear envelope/ER. During encystation HCNCp co-localized with cyst
proteins in encystation secretory vesicles (ESV) and to the cyst wall of water-resistant cysts. In mature cysts, most of the HCNCp was within the cell
body. Scale bar is 5 mM.
doi:10.1371/journal.pone.0000044.g003
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PLoS ONE | www.plosone.org 5 December 2006 | Issue 1 | e44programs MEME [44] and MAST [45] to determine whether any
of the 61 G. lamblia HCMp (Table 1) contain repeats or known
motifs or might be related to each other. Seven of the nine
similarity groups contained regular repeat patterns (Figures S1 and
S2). In addition to the repeated motifs, three groups (called VSP-
like, EGF-like, and TMK-like) contained recognizable motif
signatures. The proteins we placed in the VSP-like group had
expectation values of e
254 to e
272 against the VSP domain HMM
of the Pfam database (PF03302), while TSA 417 was e
2308
(Table 3). The EGF-like group had high similarities to the EGF
functional domain (PF00008). The TMK-like group scored highly
to a HMM constructed using alignments from the extracellular
domains from 6 of 8 E. histolytica transmembrane kinases [43]. In
addition, some members of the other groups had fewer instances of
these motifs. Several members of the TMK-like, VSP-like, and
Group 1, including HCNCp, also contained 1 or more PC6B
domains (Table 3), which have been implicated in the possible
stabilization or intracellular localization of a Kex-2 like endopro-
teinase [46].
DISCUSSION
The sequence of HCNCp is strikingly similar to the VSPs in many
respects, however its expression and trafficking largely resemble
that of the CWPs. Moreover, we discovered that the giardial
genome contains a total of 60 additional high cysteine Type 1
integral membrane proteins (HCMp) that resemble HCNCp, and
do not appear to be VSPs. The giardial isolate (‘‘WB, clone C6’’)
used for genome analyses has about 150 VSPs in its repertoire.
VSPs change under selection by antibodies in vitro and in vivo
[11,12]. However, they also switch spontaneously [25,47]. VSP
expression may also be influenced by physiological conditions,
such as intestinal proteases or growth vs. differentiation [24,32]
and may help in adaptation to growth in different host species
[48]. In contrast, HCNCp is not variable, as it was expressed in all
the Assemblage A isolates and subclones we tested.
VSPs may differ greatly in length from about 20 to 200 kDa,
frequently because of different numbers of repeated sequences
[49,50]. They often belong to small families whose genes are
recognized by the same probes or encode proteins with cross-
reactive epitopes. Many VSP sequences have been used as to
define different genetic assemblages [7,40,51]. Despite their
variability, the VSPs have strikingly constant features. They are
all highly (,11–12%) cysteine-rich Type I integral membrane
proteins, with a large proportion of the Cys residues in ‘‘CxxC’’
tetrapeptide motif, where x can be many amino acids [16].
However, the CxC motif is very rare in VSPs [7,16]. CC
sequences are rarely found in VSPs or HCMp. VSPs have
a conventional N-terminal signal peptide and least one GGCY
tetrapeptide motif near the C-terminus. Many have a Zn finger
motif. VSPs are characterized by an extremely conserved C-
terminal membrane spanning sequence and short hydrophilic
cytoplasmic anchor sequence, CRGKA. The Cys is a substrate for
palmitoylation [52], which may be a means to regulate cellular
signaling. Virtually all of the HCMp also have Cys residues in their
tails that may act as a substrate for this modification, although
Giardia has relatively few palmitoylated proteins [53,54]. While
most giardial genes have a typical consensus AGTUAAY
Figure 4. Presence Or Absence Of The HCNCp Gene And mRNA
Transcripts In Trophozoites Of 9 Giardia Strains/Subclones
(A) Genomic PCR found that the gene for HCNCp is present in all
giardial isolates except for GS/M (upper panel). Lower panel shows
tubulin controls for each isolate. (B) HCNCp mRNA transcripts were
detected in all strains/clones tested except for the most divergent
known Giardia strain infecting humans, GS/M (upper panel). Tubulin
controls for rt-PCR without reverse transcriptase (‘‘-‘‘) or plus reverse
transcriptase (‘‘+’’) are shown in the lower panel. Sizing markers are
indicated by dashes to the left side of the figure in kb.
doi:10.1371/journal.pone.0000044.g004
Table 2. Available SAGE Data For The High Cysteine Membrane Proteins (HCMp) Outlined In Table 1
..................................................................................................................................................
ORF ID 11309 15317 16318 25816 41942 91707 113213 113531 113987 114626 115066
Troph 0.02104 0.10259 0.02367 0.01315 0.02104 0.0342 0.00526 0.02104 0.06313 0.02367 0.02104
4h 0.02159 0.11065 0.04318 0.05667 0.0081 0.01619 0.0054 0.01619 0.02969 0.0054 0.0054
12h 0.02116 0.16396 0.02909 0.06611 0.00529 0.00793 0.00793 0.01322 0.03173 0.02116 0.00529
21h 0.01089 0.11976 0.00544 0.01089 0.00544 0.01633 0.01089 0 0.02722 0.00544 0
42h 0.00511 0.12764 0.02298 0.01532 0.00511 0.01021 0.01276 0.02553 0.03319 0.02298 0.00255
SAGE data are presented as percentages of all tags sampled. ORF ID numbers can be used to view the data on GiardiaDB (www.mbl.edu/Giardia).
doi:10.1371/journal.pone.0000044.t002
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..................................................................................................................................................
ORF_ID GGCY CxxC CxC MEME group TMK HMM (E value) VSP HMM (E value) EGF HMM (E value) PC6B repeats
113797* 1 29 0 VSP 0.005 2.3E-306 0.30
112633 062 8 EGF-like 0.290 4.20E-04 6.80E-40
113213 062 8 EGF-like 0.120 3.10E-04 4.10E-38
113531 062 8 EGF-like 0.280 0.002 3.80E-37
16936 042 6 EGF-like 0.270 0.028 6.70E-37
113836 062 8 EGF-like 0.072 0.007 6.80E-35
137727 062 8 EGF-like 0.200 0.003 1.40E-32
114991 052 4 EGF-like 0.160 0.009 4.30E-31
114626 062 8 EGF-like 0.210 0.002 1.50E-30
40376** 5 77 8 Group 1 4.30E-05 4.8E-23 0.01 4
16318 33 0 2 5 Group 1 0.004 9.1E-35 2.00E-29 1
15008 31 9 2Group 1 0.170 1.30E-05 0.01 1
103454 32 2 1Group 1 0.030 6.7E-17 0.16
91707 22 1 3Group 1 0.070 3.40E-06 0.01 1
7715 22 0 3Group 1 0.059 9.3E-10 0.02 1
10659 23 1 0Group 1 0.011 4.7E-14 0.07 1
25816 23 8 1Group 1 7.40E-04 7E-16 0.12
101805 22 2 1Group 1 0.036 1.1E-16 1.10
15317 12 4 2 2 Group 1 0.012 3.4E-27 2.50E-36 1
11309 16 9 3Group 1 2.70E-05 3.9E-18 0.03 2
32607 13 8 0Group 1 0.008 6.4E-48 0.13 2
16842 12 8 1Group 2 0.025 5.6E-11 0.05
15521 12 4 3Group 2 0.390 3.9E-14 0.12
39904 13 0 2Group 2 0.005 8.00E-08 0.15
91099 052 5 Group 2 0.076 0.008 5.50E-45
24880 041 7 Group 2 0.140 7.50E-04 1.20E-22
16374 01 9 6Group 2 0.037 3.50E-05 2.80E-08
17328 07 0 1 8 Group 2 2.90E-05 1.20E-08 0.03
16721 03 0 0Group 2 0.018 2.30E-05 0.03
15475 03 1 1Group 2 0.087 2.00E-06 0.04
9620 05 0 0Group 2 2.20E-04 2.50E-06 0.07
14017 04 7 0Group 2 5.70E-04 2.10E-06 0.10
22547 06 1 2Group 2 1.20E-04 2.30E-05 0.11 5
112126 23 4 0Group 3 0.010 6.1E-12 0.19
27717 13 4 0Group 3 0.009 1.4E-11 0.12
114891 13 4 0Group 3 0.009 1.9E-12 0.24
113987 13 4 0Group 3 0.011 3E-11 0.29
114930 32 4 3Group 4 0.007 1.3E-13 0.04
112828 32 4 3Group 4 0.008 1.4E-13 0.05
114089 32 4 3Group 4 0.008 2.3E-15 0.07
114617 22 3 3Group 4 0.008 2.7E-13 0.04
114042 22 4 3Group 4 0.009 1.1E-14 0.05
137715 03 6 0Group 5 0.004 5.00E-06 0.01
112432 03 5 0Group 5 0.009 5.20E-06 0.01
16716 03 6 0Group 5 0.003 3.00E-09 0.02
21321 03 6 0Group 5 0.004 1.4E-09 0.11
15250 03 2 0Group 6 0.015 2.60E-06 0.03
41942 03 0 0Group 6 0.051 2.20E-06 0.11
114470 22 1 0Group 6 0.120 1.8E-58 0.29
113512 22 1 0Group 6 0.140 1.6E-73 0.29
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PLoS ONE | www.plosone.org 7 December 2006 | Issue 1 | e44polyadenylation signal, that of the VSPs is 15 nucleotides [8,18].
Most importantly, VSPs traffic to the plasma membrane via the
ER in a constitutive secretory pathway [7,32,35]. These features
may be considered diagnostic of VSPs.
The three known cyst wall structural proteins (CWPs) are
similar to each other with a signal peptide and leucine-rich repeats
(LRR), but no TM regions [28]. The 14 Cys residues they share
are positionally conserved and they do not appear to vary among
isolates. Expression of the CWPs is greatly upregulated in
encystation and they are transported to the nascent, extracellular
cyst wall by novel encystation secretory vesicles (ESV) that are
specifically assembled during encystation [34].
Although Giardia was reported to lack a conventional Golgi
apparatus [55], we showed earlier that it could sort proteins to
constitutive and regulated secretory pathways [24,34]. Specifically,
in vegetative cells, the VSP TSA 417 is targeted to the
plasmalemma via the constitutive pathway [32]. During encysta-
tion, TSA 417 co-localizes with CWPs in the nuclear envelope and
the ER, but does not enter the ESVs or traffic to the cyst wall.
Conversely, CWPs are sequestered in the ESVs for transport to the
ORF_ID GGCY CxxC CxC MEME group TMK HMM (E value) VSP HMM (E value) EGF HMM (E value) PC6B repeats
114180 12 110 1 TMK-like 4.70E-05 1.1E-10 0.10 1
113416 12 108 1 TMK-like 1.30E-04 6.1E-11 0.12 1
113319 11 110 2 TMK-like 9.50E-05 2.4E-10 0.12 1
112673 45 6 1VSP-like 8.40E-05 4E-54 0.20 2
112135 45 6 1VSP-like 1.10E-04 6.3E-57 0.20 2
115066 45 6 0VSP-like 7.70E-05 2.1E-56 0.21 2
113801 33 4 1VSP-like 0.003 1.6E-70 0.16 1
112584 33 4 1VSP-like 0.004 5.3E-64 0.19 1
113297 33 4 1VSP-like 0.004 2.3E-65 0.83 1
137672 33 4 1VSP-like 0.002 2.3E-70 1.50 1
114852 23 4 1VSP-like 0.002 6.3E-69 0.19 1
112305 23 4 1VSP-like 0.002 3.9E-72 0.24 1
doi:10.1371/journal.pone.0000044.t003
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Table 3. cont.
..................................................................................................................................................
Table 4. HCMp’s In Model Organisms And Selected Parasite Genomes
..................................................................................................................................................
Organism Genome Size (Mbp) $10% Cysteine (.400 aa) Type1 TM (.400 aa) HCMp’s % Genome*
G. lamblia
a 12 173 152 61 0.63
T. thermophila
b 104 285 45 30 0.11
H. sapiens
c 2,910 28 9 7 0.025
E. histolytica
d 20 28 17 6 0.06
D. melanogaster
e 180 18 6 4 0.03
C. elegans
f 97 39 9 4 0.02
A. thaliana 125 6 4 0
T. gondii 80 7 3 0
C. rheinhardtii 120 3 1 0
T. brucei 30 3 1 0
P. falciparum 23 0 0 0
S. cerevisiae 12 0 0 0
C. parvum 10 0 0 0
aG. lamblia: Giardia genome ORF numbers from GiardiaDB (www.mbl.edu/Giardia):
40376,11309,25816,32607,10659,16318,15317,103454,101805,91707,7715,15008,17328,22547,9620,14017,15475,39904,16721,16842,15521,16374,91099,24880,27717,
112126,113987,114891,114042,114089,112828,114930,114617,112633,137727,113213,113836,113531,114626,114991,16936,16716,21321,137715,112432,15250,
41942,113512,114470,114180,113319,113416,112673,112135,115066,112584,113297,113801,137672,112305,11852
bT. thermophila: gi|89285635,gi|89286821,gi|89288525,gi|89288637,gi|89288695,gi|89289016,gi|89289736,gi|89290140,gi|89290464,gi|89291419,gi|89291425,
gi|89292518,gi|89292756,gi|89293702,gi|89295361,gi|89295485,gi|89295487,gi|89295488,gi|89295496,gi|89295499,gi|89295601,gi|89296595,gi|89299183,
gi|89300019,gi|89302034, gi|89302083,gi|89304603,gi|89304693,gi|89306011,gi|89306012
cH. sapiens: gi|21704279,gi|21704277,gi|14192943,gi|14192941,gi|5453766,gi|10092639,gi|4503667
dE. histolytica: gi|67476461,gi|67473447,gi|67476571,gi|67467895,gi|67476995,gi|67464660
eD. melanogaster: CG33196,CG6124,CG2086,CG15011 from FlyBase (http://flybase.org/)
fC. elegans: gi|25143262,gi|25150348,gi|25150352,gi|25150359
*% Genome defined as number of HCMp’s/predicted ORFs.
doi:10.1371/journal.pone.0000044.t004
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PLoS ONE | www.plosone.org 8 December 2006 | Issue 1 | e44cyst wall, but not found in the plasmalemma [26–28,34]. Rather
than a discrete targeting motif, most of the LRR regions of the
CWPs seem to be required for entry into the ESV and incorporation
into the cyst wall [28,34,56]. Hehl’s group also reported that
chimeras containing the LRRs from a CWP [56] and the VSP [57]
transmembrane region and tail localized to the plasmalemma inpre-
encysting cells lacking ESV. However, during encystation, the
chimera was targeted to the cyst wall via ESVs. This group has also
localized homologs of Golgi proteins to ESVs [58,59] and proposes
that they have post-ER Golgi-like sorting function.
In vegetatively growing cells, HCNCp localizes largely to the
nuclei and nuclear envelope, as it co-localizes with DAPI staining
and PDI-2 (Figure 3). Thus, it is within the innermost cisterna of
the ER and in the constitutive protein secretory pathway [32]. In
contrast to the VSPs, it is not in the more distal ER or the
plasmalemma. The implications of HCNCp within the nuclei
remain to be elucidated. In encysting cells, HCNCp clearly co-
localizes with cyst proteins within the ESV, which demarcate the
regulated secretory pathway [34]. In mature cysts, virtually all
anti-cyst epitopes are in the extracellular cyst wall and little is
detected within the cell body. However, only a fraction of HCNCp
is in the cyst wall and most appears to be in vesicular structures
throughout the cell body (Figure 3). We cannot tell if these are
remnant ESVs that have discharged the CWPs, but retain at
minimum the C-terminus of HCNCp. This is the first observation
of a protein that localizes to both the cyst wall and cell body. Since
the cell body is the precursor of the excyzoite, HCNCp may have
a function during or after excystation. Therefore, HCNCp appears
to follow a novel protein trafficking pathway, unlike those
previously characterized in Giardia. We trace HCNCp with a C-
terminal 6-amino acid epitope-tag. Thus, even the smallest
fragment detected (,21 kDa) contains the hydrophobic putative
TM region. Further studies are needed to determine the fate of the
N-terminus of HCNCp and the function, if any of the proteolytic
processing.
In addition to HCNCp, another cyst protein is proteolytically
processed during encystation. Lujan et al (1995) [26] reported that
CWP2 can be proteolytically cleaved from a 39 kDa protein to
26 kDa by an encystation specific cysteine proteinase (ESCP)
found in the lysosomal compartment [60]. We have not
determined whether ESCP or other proteinases can cleave
HCNCp, nor do we know if it can be self-cleaving. We have
found a putative subtilisin-type proprotein convertase (SPC) that is
also upregulated in encystation and localizes to the ESV (B. J.
Davids unpublished data). Interestingly, there is an SPC cleavage
site in HCNCp that would produce a C-terminal epitope-tagged
fragment of v56 kDa, which may be one of the minor fragments
seen in our immunoblot of cysts (Figure 2). The VSP TSA 417 also
undergoes endogenous proteolysis [16], but the fragments are held
together on the cell surface by disulfide bonding.
Although it is strikingly cysteine-rich, with 77 CxxC motifs,
HCNCp clearly differs from the VSPs, especially in its C-terminus.
HCNCp also has 6 CxC motifs while TSA 417, like most other
VSPs, has none. We asked whether HCNCp is unique or
resembles other proteins in Giardia. Genome-wide analyses
revealed 173 giardial proteins of $400 amino acids with $10%
Cys. 152 of these are Type 1 integral membrane proteins. Of
these, 89 have a VSP CRKGA tail and have not been considered
in our analyses. Aside from the VSPs, 61 ORFs including HCNCp
have $20 instances of CxxC/CxC and satisfy all our criteria for
a putative HCMp. The HCMp are difficult to classify and differ in
various parameters, although they form small clusters with similar
membrane spanning and or cytoplasmic sequences (Table 1), and
the occurrence of GGCY motifs (Table 3). While not all groups
had GGCY motifs, HCNCp had 5 and others within ‘‘group 1’’
had between 1 and 3. The significance of this motif in VSPs has
not been fully examined, although Nash [7] reports that mutations
in GGCY result in loss of VSP surface localization. We have not
seen HCNCp localized at the surface membranes of trophozoites
or encysting trophozoites, but it may have an important role at the
surface of excyzoites during excystation.
The HCMp also differ from each other in whether they have
a preponderance of CxxC or CxC motifs. The latter are very rare
in VSPs [7]. All have some CxxC motifs and many have no CxC,
but others have from 1 to 28 CxC sequences. From a functional
point of view [61], CxxC motifs are well-known in the active sites
of redox proteins like PDIs and thioredoxins. The identity of the
two intervening amino acids strongly affects the E
09 or redox
potential. We showed earlier that in TSA 417 [16], all detectable
Cys residues were in intramolecular disulfide bonds that were
extremely resistant to reduction in the native protein. However,
the vicinal disulfide bonds of three amino acid CxC rings are much
less stable than those of four-member CxxC rings. The functional
implications of the prevalence of CxxC vs CxC motifs in HCMp
remain to be determined.
We asked whether extremely cysteine-rich membrane proteins
are common in other organisms, especially those that live in
a microaerophilic environment similar to that of Giardia. E.
histolytica is a mucosal dwelling protozoan that also differentiates
into cysts. Both parasites require high concentrations of Cys for
growth in culture [62,63]. E. histolytica has 17 Type 1 integral
membrane proteins with $10% Cys, but only 6 of these proteins
have CxxC/CxC sequences that would qualify them as HCMp
[64]. Four of the other genomes we examined had fewer HCMp
than Giardia although T. thermophila has 30 (Table 4). However,
only 0.11% of the macronuclear T. thermophila genome is dedicated
to HCMp [65], compared to 0.63% for Giardia. Currently, these
two protozoans appear to have more HCMp than other
organisms, although analyses of additional genomes could
certainly reveal others. Genetic manipulations are not possible in
Giardia, which is tetraploid [66]. However, reverse genetics [67] in
T. thermophila could provide clues or hypotheses on functions of
HCMps.
Global comparisons of the HCMp are challenging as they group
differently depending on the parameter used. Within the giardial
HCMp, recognizable motifs (Figures S1 and S2) enabled us to
classify them into subgroups (Table 3). These subcategories may
represent specific classes of HCMp with various functions. It will
be important to characterize different members of each MEME
category to determine if their group similarity can predict possible
expression, localization, and function during different stages of
giardial differentiation. Presently, we can say that HCNCp has
structural characteristics like that of VSPs, but is regulated and
expressed similar to a CWP. It is interesting that the known
giardial surface proteins are all cysteine-rich. This may help
explain the high requirement of Giardia for Cys for growth and
survival [62,68]. HCNCp is a member of a large group of cysteine-
rich, non-VSP, Type 1 integral membrane proteins, which are
rare to absent in the majority of genomes examined. The exact
functions of HCNCp and other HCMp, their evolutionary origins,
and their overall importance to the biology of G. lamblia remain to
be determined.
MATERIALS AND METHODS
Giardial isolates, cultivation and encystation
We used isolate WB clone C6 (ATCC 50803; [6]; human,
Afghanistan) unless otherwise indicated. We tested expression of
Novel Cysteine-Rich Proteins
PLoS ONE | www.plosone.org 9 December 2006 | Issue 1 | e44HCNCp in trophozoites of WB C6 subclones (1F, E6 [24]), A6
(ATCC 50583; [69]), and strains LT ([70]; human, Puerto Rico),
RB (isolated from a patient infected in Turkey), D3 (ATCC
203334, isolated from a dog Calgary, Alberta, Canada, 1986), Bris
([71], human, Australia), and GS clone H7 (GS/M; ATCC 50581;
[72], human, Alaska). Parasites were grown in modified TYI-S33
medium and encysted as described [37].
Production of polyclonal anti-cyst antibody
Polyclonal antiserum against in vitro purified water-resistant cysts
was raised in rabbits as described [73].
mRNA expression patterns
Serial Analysis of Gene Expression (SAGE) libraries were
constructed using ,10 mg of total RNA isolated from TRIzol
(Invitrogen, Carlsbad, CA) extractions of trophozoites and
encysting cells (4, 12, 21, 42 hr) following the I-SAGE protocol
(Invitrogen). Recombinant pZero1 clones produced by SAGE
were purified using GeneMachines RevPrep Orbit (San Carlos,
CA) and were sequenced on an ABI 3730xl DNA sequencer
(Applied Biosystems, Foster City, CA). Sequences collected were
analyzed with software created at the MBL specifically for Giardia
SAGE analyses. The SAGE software extracts ditag sequences from
the ABI 3730xl results according to the SAGE sequence grammar,
parses out individual SAGE tags, excludes tags with sequence
ambiguities, and reduces all SAGE tags to a look-up table of
unique SAGE tag sequences and their observed frequencies
among all of the Giardia SAGE libraries. SAGE tags not found
more than once in at least one SAGE library were excluded from
analyses as putative sequencing error, unless the tag sequence had
a perfect match to available genome data. The unique tag
sequences were mapped to all available Giardia ‘‘giardia14’’
genome assembly contigs (www.mbl.edu/Giardia) to determine
the identity of expressed genes. The 15 bp SAGE tags were
mapped to the assembly based on exact sequence matches.
HCNCp mRNA expression was verified by Northern analysis.
10 mg of total RNA was extracted from trophozoites and encysting
cells as above and separated on a denaturing RNA gel, transferred
to a ZetaProbe filter (Bio-Rad Laboratories, Hercules, CA), and
hybridized as described [28]. The strand-specific 244 bp probe for
HCNCp was made using primers ‘‘Nprobe-for’’ (59GCAG-
CATTCCTACCCGTTAT39) and ‘‘Nprobe-rev’’ (59TCCAAA-
CATTGCGTTGATTC39) in combination with the labeling kit
Prime-it II (Stratagene, La Jolla, CA). The probed and washed
filter was imaged on a Storm 860 phosphoimager (Molecular
Dynamics, Sunnyvale, CA).
Selectable transformation and epitope tagging
The promoter and coding sequences for HCNCp were amplified
from 200 ng of genomic DNA using the forward primer
‘‘HCNCp-for’’ (59-ACAAGCTTTCACAGGATGTGGACGAT-
39) and the reverse primer ‘‘HCNCp-rev’’ (59-AAATGGGCCC-
CACAGCTTTGCTCCTAC-39) and the GeneAmp XL PCR kit
(Applied Biosystems, Branchburg, NJ) by standard conditions at
a final concentration of 1.2 mM Mg(OAc)2. Conditions for PCR
were an initial denaturation at 95uC for 5 min, 4 cycles of: 95uC
50 sec, 50uC 1 min, 72uC 6 min; 31 cycles of: 95uC 50 sec, 55uC
1 min, 72uC 6 min; and a final extension for 10 min at 72uC (MJ
Research, Waltham, MA). The ,4 kb product was gel purified
using QIAquick gel extraction kit (Qiagen; Valencia, CA) and
approximately 1 mg of each PCR product or AU1-epitope tagging
Giardia vector [74] were first digested with Apa1 for 1 hr 37uC,
cleaned with QIAquick for PCR products, digested with HindIII
for 1 hr 37uC, and gel purified using QIAquick gel extraction kit.
The vector was de-phosphorylated using shrimp alkaline phos-
phatase (Promega; Madison, WI) by standard methods and
purified using QIAquick. The digested vector and PCR fragments
were ligated (T4 DNA ligase; Roche, Nutley, NJ) overnight at 4uC,
transformed into JM109 competent cells (Promega), and plasmids
screened by size for automated sequencing of clones containing
full length HCNCp (GenBank accession number DQ144994). WB
clone C6 trophozoites were electroporated with 50 mg of plasmid
containing HCNCp and were selected and maintained by
puromycin resistance [39]. Recombinant clones were purified
using GeneMachines RevPrep Orbit, sequenced on an ABI 3730xl
DNA sequencer (Applied Biosystems), and assembled using the
computer program PHRAP [75].
Expression of HCNCp
Trophozoite, encysting cells, and cyst antigens from Giardia stably
expressing the AU1-tagged HCNCp gene or non-transfected
control cells were processed for Western analysis [76]. Because of
the large size of HCNCp, transfer buffer contained 20% MeOH/
0.1% SDS. Blotted proteins were blocked overnight in PBST
(PBS+0.05% Tween 20) containing 5% milk, probed in rabbit
anti-AU1 antibody (1/5,000 in PBST/0.1% milk; Bethyl Labo-
ratories, Montgomery, TX) or antibody to the constitutive protein
taglin (1/700 in PBST/0.1% milk; loading control; [77]) for
1.5 hr, washed 36 over 30 min in PBST, incubated in Zymax
goat anti-rabbit (1/8,000; Zymed Laboratories/Invitrogen) or
Zymax goat anti-mouse (1/5,000; Zymed Laboratories/Invitro-
gen) antibodies for 1 hr, washed 36 in PBST over 30 min, and
developed in ECL (Amersham Biosciences, Piscataway, NJ).
Immunolocalization of HCNCp and CWP
Transfected parasites stably expressing AU1-tagged HCNCp or
non-transfected control cells were prepared for immunofluores-
cence assay (IFA) by methods similar to Abel et al., 2001 [21].
Giardial trophozoites or encysting cells were allowed to attach to
glass coverslips coated with 0.1% polyethylenimine (Sigma, St.
Louis, MO) in PBS on a slide warmer at 37uC. Water-resistant
cysts were allowed to dry onto the coverslip and then placed in
IFA block as described below. Attached cells were fixed in 100%
methanol (220uC) for 10 min, dried, and stored overnight at
room temperature or permeabilized immediately in 0.5% Triton-
X 100 for 10 min, and placed in IFA block (10% goat serum, 1%
glycerol, 0.1% bovine serum albumin, 0.1% fish gelatin, and
0.04% sodium azide in PBS) for 1 hr. Cells were incubated for
1 hr in primary antibody (anti-AU1 mAb diluted 1/500 in IFA
block; Covance, Berkeley, CA; or rabbit polyclonal anti-cyst (1/
250 in IFA block)), washed 46 5 min in PBS, and incubated in
goat anti-mouse FITC-labeled (1/100 in IFA block; Pierce
Biotechnology, Inc., Rockford, IL) or goat-anti rabbit TRITC-
labeled (1/100 Zymed Laboratories/Invitrogen) secondary anti-
bodies for 1 hr, washed 465 min in PBS, post-fixed in 4% PFA
for 7 min, rinsed 26 in PBS, and mounted with ProLong Gold
with DAPI (Invitrogen). Cells were screened on an E800 Nikon
(New York City, NY) microscope with an EXFO (Vanier, Canada)
X-cite fluorescent 120W metal halide illuminator and imaged with
a DMX 1200F Nikon fluorescence sensitive digital camera.
RtPCR and genomic PCR
cDNA was prepared directly from 10
4 log-phase trophozoites
(SuperScript
TM III CellsDirect cDNA synthesis system, Invitro-
gen). HCNCp-specific internal primers were: 59-GGAAAACG-
GTGACCTTATTGTG-39 (forward) and 59-GTCTACCAG-
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tubulin were: 59-CGTTCAACACGTTCTTCTCG-39 (forward)
and 59-ATGTCGTACATGGCCTCGTT-39 (reverse). 3 ml of the
cDNA template in combination with 0.2 mM dNTP mix, 2 mM
MgSO4, 0.25 mM each primer, and 1 U Platinum Taq high
fidelity polymerase (Invitrogen) was used in a standard PCR
reaction. Conditions for PCR were an initial denaturation at 95uC
for 3 min, 36 cycles of: 95uC 1 min, 50uC 1 min, 72uC 2 min, and
a final extension for 7 min at 72uC.
Genomic DNA was prepared from all strains and subclones
using DNA STAT-60
TM (Tel-Test, Inc., Friendswood, TX) by
manufacturer protocols. Conditions for genomic PCR were as
described above using ,200 ng of DNA as template.
Bioinformatic Analyses
A profile Hidden Markov Model (HMM) of the Entamoeba histolytica
transmembrane kinase (TMK) extracellular domain [43] was
created with HMMER version 2.3.2 [78]. The HMM’s for VSP
(PF03302) and EGF (PF00008) were from the Pfam database [79].
Conservative nucleotide or amino acid motifs were detected using
Multiple Em for Motif Elicitation (MEME) [44] and Motif
Alignment & Search Tool (MAST) [45], predication of signal
peptides using SignalP 3.0 [80], and prediction of transmembrane
domains using transmembrane Hidden Markov Model
(TMHMM) 2.0 [81]. A custom PERL script was used to search
genomes for cysteine-rich protein sequences containing CxC and/
or CxxC motifs (A. G. McArthur). The PC6B motifs present in
HCMp’s were found using a regular expression constructed from
the published consensus sequence: Cx2Cx3Cx2Cx5-7Cx2Cx10-15
Cx3C [46].
SUPPORTING INFORMATION
Table S1 Cysteine-Rich Proteins Not Classified As HCMp
Because They Are Too Short And/OR Have , 20 CxxC + CxC’s
Found at: doi:10.1371/journal.pone.0000044.s001 (0.04 MB
PDF)
Figure S1 Diagram Of MEME/MAST Analyses Of The 9
HCMp Groupings
Found at: doi:10.1371/journal.pone.0000044.s002 (0.29 MB
PDF)
Figure S2 Motif Sequences Found By MEME Analysis For The
9 HCMp Groupings
Found at: doi:10.1371/journal.pone.0000044.s003 (0.06 MB
PDF)
ACKNOWLEDGMENTS
We thank Michael Gilbert for his initial input. We thank Sarah Williams
for her skilled technical support. We thank Rodney Adam (University of
Arizona) for examining our HCMp ORF list to be sure we did not classify
a true VSP as HCMp. We are grateful to Mitchell Sogin and Hilary
Morrison for their interest in HCMp’s and for providing genomic
resources.
Author Contributions
Conceived and designed the experiments: AM FG BD DR. Performed the
experiments: BD DR SB SP. Analyzed the data: AM FG BD DR SB SP
MC. Contributed reagents/materials/analysis tools: AM. Wrote the paper:
AM FG BD. Other: Provided grant funding: FG AM.
REFERENCES
1. Wolfe MS (1992) Giardiasis. Clin Microbiol Rev 5: 93–100.
2. Adam RD (1991) The biology of Giardia spp. Microbiological Reviews 55:
706–732.
3. Savioli L, Smith H, Thompson A (2006) Giardia and Cryptosporidium join the
‘Neglected Diseases Initiative’. Trends Parasitol 22: 203–208.
4. Marshall MM, Naumovitz D, Ortega Y, Sterling CR (1997) Waterborne
protozoan pathogens. Clin Microbiol Rev 10: 67–85.
5. Thompson RC, Hopkins RM, Homan WL (2000) Nomenclature and genetic
groupings of Giardia infecting mammals. Parasitol Today 16: 210–213.
6. Smith PD, Gillin FD, Spira WM, Nash TE (1982) Chronic giardiasis: studies on
drug sensitivity, toxin production, and host immune response. Gastroenterology
83: 797–803.
7. Nash TE (2002) Surface antigenic variation in Giardia lamblia. Mol Microbiol
45: 585–590.
8. Adam RD (2001) Biology of Giardia lamblia. Clin Microbiol Rev 14: 447–475.
9. Adam RD, Aggarwal A, Lal AA, de La Cruz VF, McCutchan T, et al. (1988)
Antigenic variation of a cysteine-rich protein in Giardia lamblia. J Exp Med 167:
109–118.
10. Gillin FD, Hagblom P, Harwood J, Aley SB, Reiner DS, et al. (1990) Isolation
and expression of the gene for a major surface protein of Giardia lamblia. Proc
Natl Acad Sci U S A 87: 4463–4467.
11. Nash TE, Aggarwal A, Adam RD, Conrad JT, Merritt JW Jr. (1988) Antigenic
variation in Giardia lamblia. J Immunol 141: 636–641.
12. Nash TE (1989) Antigenic variation in Giardia lamblia. Exp Parasitol 68:
238–241.
13. Nash TE, Banks SM, Alling DW, Merritt JW Jr., Conrad JT (1990) Frequency
of variant antigens in Giardia lamblia. Exp Parasitol 71: 415–421.
14. Nash TE, Merritt JW Jr., Conrad JT (1991) Isolate and epitope variability in
susceptibility of Giardia lamblia to intestinal proteases. Infect Immun 59:
1334–1340.
15. Nash T (1992) Surface antigen variability and variation in Giardia lamblia.
Parasitol Today 8: 229–234.
16. Aley SB, Gillin FD (1993) Giardia lamblia: post-translational processing and
status of exposed cysteine residues in TSA 417, a variable surface antigen. Exp
Parasitol 77: 295–305.
17. Aley SB, Gillin FD (1995) Specialized surface adaptations of Giardia lamblia.
Infect Agents Dis 4: 161–166.
18. Svard SG, Meng TC, Hetsko ML, McCaffery JM, Gillin FD (1998)
Differentiation-associated surface antigen variation in the ancient eukaryote
Giardia lamblia. Mol Microbiol 30: 979–989.
19. Gillin FD, Reiner DS, McCaffery JM (1996) Cell biology of the primitive
eukaryote Giardia lamblia. Annu Rev Microbiol 50: 679–705.
20. Eichinger D (2001) Encystation in parasitic protozoa. Curr Opin Microbiol 4:
421–426.
21. Abel ES, Davids BJ, Robles LD, Loflin CE, Gillin FD, et al. (2001) Possible roles
of protein kinase A in cell motility and excystation of the early diverging
eukaryote Giardia lamblia. J Biol Chem 276: 10320–10329.
22. Reiner DS, Hetsko ML, Meszaros JG, Sun CH, Morrison HG, et al. (2003)
Calcium signaling in excystation of the early diverging eukaryote, Giardia
lamblia. J Biol Chem 278: 2533–2540.
23. Larocque R, Nakagaki K, Lee P, Abdul-Wahid A, Faubert GM (2003) Oral
immunization of BALB/c mice with Giardia duodenalis recombinant cyst wall
protein inhibits shedding of cysts. Infect Immun 71: 5662–5669.
24. Meng TC, Hetsko ML, Gillin FD (1993) Antigenic switching of TSA 417,
a trophozoite variable surface protein, following completion of the life cycle of
Giardia lamblia. Infect Immun 61: 5394–5397.
25. Nash TE, Lujan HT, Mowatt MR, Conrad JT (2001) Variant-specific surface
protein switching in Giardia lamblia. Infect Immun 69: 1922–1923.
26. Lujan HD, Mowatt MR, Conrad JT, Bowers B, Nash TE (1995) Identification
of a novel Giardia lamblia cyst wall protein with leucine-rich repeats.
Implications for secretory granule formation and protein assembly into the cyst
wall. J Biol Chem 270: 29307–29313.
27. Mowatt MR, Lujan HD, Cotten DB, Bowers B, Yee J, et al. (1995)
Developmentally regulated expression of a Giardia lamblia cyst wall protein
gene. Mol Microbiol 15: 955–963.
28. Sun CH, McCaffery JM, Reiner DS, Gillin FD (2003) Mining the Giardia
lamblia genome for new cyst wall proteins. J Biol Chem 278: 21701–21708.
29. Ortega-Barria E, Ward HD, Evans JE, Pereira ME (1990) N-acetyl-D-
glucosamine is present in cysts and trophozoites of Giardia lamblia and serves
as receptor for wheatgerm agglutinin. Mol Biochem Parasitol 43: 151–165.
30. Jarroll EL, Manning P, Lindmark DG, Coggins JR, Erlandsen SL (1989) Giardia
cyst wall-specific carbohydrate: evidence for the presence of galactosamine. Mol
Biochem Parasitol 32: 121–131.
31. Karr CD, Jarroll EL (2004) Cyst wall synthase: N-acetylgalactosaminyltransfer-
ase activity is induced to form the novel N-acetylgalactosamine polysaccharide in
the Giardia cyst wall. Microbiology 150: 1237–1243.
32. McCaffery JM, Faubert GM, Gillin FD (1994) Giardia lamblia: traffic of
a trophozoite variant surface protein and a major cyst wall epitope during
growth, encystation, and antigenic switching. Exp Parasitol 79: 236–249.
Novel Cysteine-Rich Proteins
PLoS ONE | www.plosone.org 11 December 2006 | Issue 1 | e4433. Svard SG, Hagblom P, Palm JE (2003) Giardia lamblia – a model organism for
eukaryotic cell differentiation. FEMS Microbiol Lett 218: 3–7.
34. Reiner DS, McCaffery M, Gillin FD (1990) Sorting of cyst wall proteins to
a regulated secretory pathway during differentiation of the primitive eukaryote,
Giardia lamblia. Eur J Cell Biol 53: 142–153.
35. Hehl AB, Marti M (2004) Secretory protein trafficking in Giardia intestinalis.
Mol Microbiol 53: 19–28.
36. Gottig N, Elias EV, Quiroga R, Nores MJ, Solari AJ, et al. (2006) Active and
passive mechanisms drive secretory granule biogenesis during differentiation of
the intestinal parasite Giardia lamblia. J Biol Chem 281: 18156–18166.
37. Sun CH, Palm D, McArthur AG, Svard SG, Gillin FD (2002) A novel Myb-
related protein involved in transcriptional activation of encystation genes in
Giardia lamblia. Mol Microbiol 46: 971–984.
38. Knodler LA, Svard SG, Silberman JD, Davids BJ, Gillin FD (1999)
Developmental gene regulation in Giardia lamblia: first evidence for an
encystation-specific promoter and differential 59 mRNA processing. Mol
Microbiol 34: 327–340.
39. Knodler LA, Noiva R, Mehta K, McCaffery JM, Aley SB, et al. (1999) Novel
protein-disulfide isomerases from the early-diverging protist Giardia lamblia.
J Biol Chem 274: 29805–29811.
40. Adam RD (2000) The Giardia lamblia genome. Int J Parasitol 30: 475–484.
41. McArthur AG, Morrison HG, Nixon JE, Passamaneck NQ, Kim U, et al. (2000)
The Giardia genome project database. FEMS Microbiol Lett 189: 271–273.
42. Baron M (2003) An overview of the Notch signalling pathway. Semin Cell Dev
Biol 14: 113–119.
43. Beck DL, Boettner DR, Dragulev B, Ready K, Nozaki T, et al. (2005)
Identification and gene expression analysis of a large family of transmembrane
kinases related to the Gal/GalNAc lectin in Entamoeba histolytica. Eukaryot
Cell 4: 722–732.
44. Bailey TL, Elkan C (1994) Fitting a mixture model by expectation maximization
to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 2: 28–36.
45. Bailey TL, Gribskov M (1998) Combining evidence using p-values: application
to sequence homology searches. Bioinformatics 14: 48–54.
46. Nakagawa T, Murakami K, Nakayama K (1993) Identification of an isoform
with an extremely large Cys-rich region of PC6, a Kex2-like processing
endoprotease. FEBS Lett 327: 165–171.
47. Bienz M, Siles-Lucas M, Wittwer P, Muller N (2001) vsp gene expression by
Giardia lamblia clone GS/M-83-H7 during antigenic variation in vivo and in
vitro. Infect Immun 69: 5278–5285.
48. Singer SM, Elmendorf HG, Conrad JT, Nash TE (2001) Biological selection of
variant-specific surface proteins in Giardia lamblia. J Infect Dis 183: 119–124.
49. Yang YM, Adam RD (1995) Analysis of a repeat-containing family of Giardia
lamblia variant-specific surface protein genes: diversity through gene duplication
and divergence. J Eukaryot Microbiol 42: 439–444.
50. Mowatt MR, Nguyen BY, Conrad JT, Adam RD, Nash TE (1994) Size
heterogeneity among antigenically related Giardia lamblia variant-specific
surface proteins is due to differences in tandem repeat copy number. Infect
Immun 62: 1213–1218.
51. Nash TE, Keister DB (1985) Differences in excretory-secretory products and
surface antigens among 19 isolates of Giardia. J Infect Dis 152: 1166–1171.
52. Touz MC, Conrad JT, Nash TE (2005) A novel palmitoyl acyl transferase
controls surface protein palmitoylation and cytotoxicity in Giardia lamblia. Mol
Microbiol 58: 999–1011.
53. Hiltpold A, Frey M, Hulsmeier A, Kohler P (2000) Glycosylation and
palmitoylation are common modifications of giardia variant surface proteins.
Mol Biochem Parasitol 109: 61–65.
54. Das S, Traynor-Kaplan A, Reiner DS, Meng TC, Gillin FD (1991) A surface
antigen of Giardia lamblia with a glycosylphosphatidylinositol anchor. J Biol
Chem 266: 21318–21325.
55. Marti M, Hehl AB (2003) Encystation-specific vesicles in Giardia: a primordial
Golgi or just another secretory compartment? Trends Parasitol 19: 440–446.
56. Hehl AB, Marti M, Kohler P (2000) Stage-specific expression and targeting of
cyst wall protein-green fluorescent protein chimeras in Giardia. Mol Biol Cell
11: 1789–1800.
57. Marti M, Li Y, Schraner EM, Wild P, Kohler P, et al. (2003) The secretory
apparatus of an ancient eukaryote: protein sorting to separate export pathways
occurs before formation of transient Golgi-like compartments. Mol Biol Cell 14:
1433–1447.
58. Marti M, Regos A, Li Y, Schraner EM, Wild P, et al. (2003) An ancestral
secretory apparatus in the protozoan parasite Giardia intestinalis. J Biol Chem
278: 24837–24848.
59. Stefanic S, Palm D, Svard SG, Hehl AB (2006) Organelle proteomics reveals
cargo maturation mechanisms associated with Golgi-like encystation vesicles in
the early-diverged protozoan Giardia lamblia. J Biol Chem 281: 7595–7604.
60. Touz MC, Nores MJ, Slavin I, Carmona C, Conrad JT, et al. (2002) The
activity of a developmentally regulated cysteine proteinase is required for cyst
wall formation in the primitive eukaryote Giardia lamblia. J Biol Chem 277:
8474–8481.
61. Woycechowsky KJ, Raines RT (2003) The CXC motif: a functional mimic of
protein disulfide isomerase. Biochemistry 42: 5387–5394.
62. Lujan HD, Nash TE (1994) The uptake and metabolism of cysteine by Giardia
lamblia trophozoites. J Eukaryot Microbiol 41: 169–175.
63. Gillin FD, Diamond LS (1981) Entamoeba histolytica and Giardia lamblia:
growth responses to reducing agents. Exp Parasitol 51: 382–391.
64. Loftus B, Anderson I, Davies R, Alsmark UC, Samuelson J, et al. (2005) The
genome of the protist parasite Entamoeba histolytica. Nature 433: 865–868.
65. Eisen JA, Coyne RS, Wu M, Wu D, Thiagarajan M, et al. (2006) Macronuclear
Genome Sequence of the Ciliate Tetrahymena thermophila, a Model Eukaryote.
PLoS Biol 4.
66. Bernander R, Palm JE, Svard SG (2001) Genome ploidy in different stages of the
Giardia lamblia life cycle. Cell Microbiol 3: 55–62.
67. Howard-Till RA, Yao MC (2006) Induction of gene silencing by hairpin RNA
expression in Tetrahymena thermophila reveals a second small RNA pathway.
Mol Cell Biol, In Press.
68. Gillin FD, Diamond LS (1981) Entamoeba histolytica and Giardia lamblia:
effects of cysteine and oxygen tension on trophozoite attachment to glass and
survival in culture media. Exp Parasitol 52: 9–17.
69. Aggarwal A, Nash TE (1988) Antigenic variation of Giardia lamblia in vivo.
Infect Immun 56: 1420–1423.
70. Smith PD, Gillin FD, Kaushal NA, Nash TE (1982) Antigenic analysis of
Giardia lamblia from Afghanistan, Puerto Rico, Ecuador, and Oregon. Infect
Immun 36: 714–719.
71. Capon AG, Upcroft JA, Boreham PF, Cottis LE, Bundesen PG (1989)
Similarities of Giardia antigens derived from human and animal sources.
Int J Parasitol 19: 91–98.
72. Aggarwal A, Merritt JW Jr., Nash TE (1989) Cysteine-rich variant surface
proteins of Giardia lamblia. Mol Biochem Parasitol 32: 39–47.
73. Gillin FD, Reiner DS, Gault MJ, Douglas H, Das S, et al. (1987) Encystation
and expression of cyst antigens by Giardia lamblia in vitro. Science 235:
1040–1043.
74. Weiland ME, Palm JE, Griffiths WJ, McCaffery JM, Svard SG (2003)
Characterisation of alpha-1 giardin: an immunodominant Giardia lamblia
annexin with glycosaminoglycan-binding activity. Int J Parasitol 33: 1341–1351.
75. Gordon D, Abajian C, Green P (1998) CONSED: a graphical tool for sequence
finishing. Genome Res 8: 195–202.
76. Davids BJ, Mehta K, Fesus L, McCaffery JM, Gillin FD (2004) Dependence of
Giardia lamblia encystation on novel transglutaminase activity. Mol Biochem
Parasitol 136: 173–180.
77. Ward HD, Keusch GT, Pereira ME (1990) Induction of a phosphomannosyl
binding lectin activity in Giardia. Bioessays 12: 211–215.
78. Eddy SR (1998) Profile hidden Markov models. Bioinformatics 14: 755–763.
79. Bateman A, Coin L, Durbin R, Finn RD, Hollich V, et al. (2004) The Pfam
protein families database. Nucleic Acids Res 32 Database issue: D138–141.
80. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of
signal peptides: SignalP 3.0. J Mol Biol 340: 783–795.
81. Krogh A, Larsson B, von Heijne G, Sonnhammer EL (2001) Predicting
transmembrane protein topology with a hidden Markov model: application to
complete genomes. J Mol Biol 305: 567–580.
Novel Cysteine-Rich Proteins
PLoS ONE | www.plosone.org 12 December 2006 | Issue 1 | e44